[HTML][HTML] Donor lymphocyte infusions used to treat mixed-chimeric and high-risk patient populations in the relapsed and nonrelapsed settings after allogeneic …

LE Caldemeyer, LP Akard, JR Edwards… - Biology of Blood and …, 2017 - Elsevier
… HSCT may indicate an inadequacy in the GVM effect, predicting disease relapse if pre-emptive …
Strict assignment of acute GVHD (aGVHD) or chronic GVHD (cGVHD) after DLI can be …

Extracorporeal photopheresis for GVHD prophylaxis after reduced intensity conditioning allogeneic hematopoietic stem cell transplantation: a prospective multicenter …

M Michallet, M Sobh, F Garban, CE Bulabois… - Leukemia & …, 2018 - Taylor & Francis
GVHD by increasing donor regulatory T cells thus indirectly … a cumulative incidence of
severe acute GVHD of 19% by 6 … cells, an increase of NK cells (CD3- CD56+) and a decrease

[HTML][HTML] Prognostic Factors for Postrelapse Survival after ex Vivo CD34+-Selected (T Cell-Depleted) Allogeneic Hematopoietic Cell Transplantation in Multiple …

A Gomez-Arteaga, GL Shah, RE Baser… - Biology of Blood and …, 2020 - Elsevier
… differential patterns and predictors of postrelapse survival for … 3 to 4 months later by a dose
of 5 × 10 5 CD3 + cells/kg, and … The median time to onset of acute GVHD was 49 days post-…

[HTML][HTML] T cell receptor excision circle (TREC) monitoring after allogeneic stem cell transplantation; a predictive marker for complications and clinical outcome

A Gaballa, M Sundin, A Stikvoort, M Abumaree… - International Journal of …, 2016 - mdpi.com
chimerism had faster immune reconstitution as measured by TREC levels than adult patients
who reach full donor chimerism early … OS, decreased incidence of severe GVHD (acute and …

Impact of T-cell chimerism on relapse after cord blood transplantation for hematological malignancies: Nagoya Blood and Marrow Transplantation Group study

…, Y Ozawa, T Goto, N Imahashi, T Nishida… - Bone marrow …, 2017 - nature.com
… at day 28 was MC developed grades II–IV acute GvHD in this study. It is suggested that …
Acute GvHD is a strong predictor of full donor CD3+ T cell chimerism after reduced intensity

[HTML][HTML] Cytotoxicity of donor natural killer cells to allo-reactive T cells are related with acute graft-vs.-host-disease following allogeneic stem cell transplantation

L Sheng, Q Mu, X Wu, S Yang, H Zhu, J Wang… - Frontiers in …, 2020 - frontiersin.org
… , and investigated their relationship with acute GVHD (… of donor NK cells on the proliferation
of autogeneic CD3 + T … the main reasons why the predictive value of the donor NK CD107a …

T-cell-replete haploidentical stem cell transplantation using low-dose antithymocyte globulin in children with relapsed or refractory acute leukemia

…, S Kobayashi, Y Ohara, M Ito, T Waragai… - International Journal of …, 2018 - Springer
… of grade II to IV acute GvHD was 30.7%. We also consider that … Several predictive factors for
overall survival were evaluated … received higher doses of CD3+ cells was excellent, although …

[HTML][HTML] … Conditioning Regimen before T Cell–Replete Haploidentical Transplantation with Post-Transplant Cyclophosphamide for Acute Myeloid Leukemia: A …

T Pagliardini, L Castagna, S Harbi… - Biology of Blood and …, 2019 - Elsevier
… achieved full donor chimerism (74 before day 45 and 21 after day … II to IV and III to IV acute
GVHD at day 100 were 23% and 7%, … analysis did not identify any predictive factor of GVHD. …

Evaluation of risk factors for and subsequent mortality from poor graft function (PGF) post allogeneic stem cell transplantation

A Prabahran, R Koldej, L Chee, E Wong… - Leukemia & …, 2021 - Taylor & Francis
… This analysis identifies risk factors predictive of PGF and … donor chimerism had poorer
outcomes, we decided to evaluate our … Using the three variables of grade 3–4 acute GVHD, …

[HTML][HTML] … between CD34+ and CD3+ T-cells in allogeneic grafts and acute graft-versus-host disease in children undergoing allogeneic hematopoietic stem cell …

D Yao, B Li, X Chu, J Pan, L Meng, Y Hu, L Gao… - Transplant …, 2023 - Elsevier
Acute graft-versus-host disease (aGVHD) is a major … to determine the predictive value of
the graft cell subsets for the … hematopoietic recovery and stable full donor chimerism, with the …